PlainRecalls
FDA Drug Moderate Class II Terminated

Enalapril maleate and hydrochlorothiazide tablets USP, 10/25 mg, 100-count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India, NDC 60505-0209-1

Reported: July 15, 2015 Initiated: May 29, 2015 #D-1215-2015

Product Description

Enalapril maleate and hydrochlorothiazide tablets USP, 10/25 mg, 100-count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India, NDC 60505-0209-1

Reason for Recall

Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.

Details

Recalling Firm
Apotex Inc.
Units Affected
4,584 bottles
Distribution
Nationwide, Hawaii and Puerto Rico
Location
Toronto, N/A

Frequently Asked Questions

What product was recalled?
Enalapril maleate and hydrochlorothiazide tablets USP, 10/25 mg, 100-count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India, NDC 60505-0209-1. Recalled by Apotex Inc.. Units affected: 4,584 bottles.
Why was this product recalled?
Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 15, 2015. Severity: Moderate. Recall number: D-1215-2015.